Clinical Trials Browser

Phase 2 × Neoplasms × sintilimab × Clear all

NCT07018063 2025-06-12

YOUNG-NEOS

Phase 2 Not yet recruiting

Gastrointestinal

Neoplasms, Stomach Neoplasms

NCT04371796 2020-05-01

Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT03874000 2019-03-19

SMART

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Neoplasms